Publication | Closed Access

Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model

HemodialysisNeurodegenerative DiseasesAlzheimer's DiseaseAgingApp/ps1 Mouse ModelMedicineDementiaVascular DementiaDegenerative PathologyNeurochemical BiomarkersDialysis TherapyNeurologyNeuroscienceNeurodegenerationAlzheimer-associated PhenotypesAging-associated DiseaseChronic Kidney DiseaseNephrology